Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical Data
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Purpose
Patients with myelodysplastic syndromes (MDS) exhibit diverse disease trajectories necessitating different clinical approaches ranging from watch-and-wait strategies to hematopoietic stem cell transplantation. Existing risk scores like the IPSS-R or EASIX provide static risk stratification at diagnosis but do not capture evolving disease dynamics. We address this problem by introducing a dynamic, data-driven approach to predict short-term mortality risks repeatedly, across the patient’s disease course.
Materials and methods
We develop a machine learning model based on gradient-boosted decision trees to estimate one-year mortality risks from both longitudinal parameters from blood values and diagnosis-based features. We train the model on a dataset of patients from the MDS Registry Düsseldorf (n=1024) and validate on patients from University Hospitals Heidelberg (n=286) and Mannheim (n=31).
Results
Validations on independent cohorts achieved AUROC scores of around 0.8 and better predictive performance for one-year survival compared to a diagnosis-only baseline model. The model accurately predicted mortality risks as early as within the first 90 days of diagnosis. Feature importance analysis revealed clinically plausible feature-label relations, supporting interpretability.
Conclusion
This dynamic risk model enables continuous, individualized assessment of one-year mortality risk in MDS patients, offering a supplement to static scores used at diagnosis. Our results highlight the utility and importance of including longitudinal parameters in risk assessment analysis.
